Products & SolutionsWho We ServeCase StudiesContact Us
Login
Search Articles

Global oncology firm plans $300 million expansion of New Jersey campus

BeOne Medicines secures $34 million in tax incentives for new Princeton-area manufacturing facility
BeOne Medicines' expansion will take place at its biologics manufacturing facility and clinical R&D center of excellence, depicted here, at the Princeton West Innovation Campus in Hopewell, New Jersey. (BeOne Medicines)
BeOne Medicines' expansion will take place at its biologics manufacturing facility and clinical R&D center of excellence, depicted here, at the Princeton West Innovation Campus in Hopewell, New Jersey. (BeOne Medicines)
CoStar News
July 23, 2026 | 10:26 P.M.

RELATED ARTICLES

A global oncology company plans a $300 million expansion of its manufacturing facility near Princeton in the Garden State, a project that has won it roughly $34 million in tax incentives from the New Jersey Economic Development Authority.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Explore CoStar

Already A Subscriber? Sign In

Follow us on Social Media